LUTATHERA CA sol perf 370 MBq/ml flac

7680665800028 CH-66580 V10XX04 17.02.
LUTATHERA CA sol perf 370 MBq/ml flac
LUTATHERA CA sol perf 370 MBq/ml flac
LUTATHERA CA sol perf 370 MBq/ml flac
1 / 3
google

Details

Product number
6658001
CPT
-
Packaging group
20.5 - 25
Unit
ml
Composition
lutetium(177-Lu(CA)) oxodotreotidum 370 MBq, acidum aceticum, natrii acetas, acidum penteticum, natrii chloridum, natrii hydroxidum, acidum gentisicum, E 300, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.24 mg.

Articles (1)

Lutathera CA 370 MBq/ml, Infusionslösung
Infusionslösung
20.5 - 25
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/12/2024
Professional SmPC
Français
13/12/2024
Professional SmPC
Italien
13/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
370.0 MBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance ANTON
(N/A)
- Substance HNIDK
(N/A)
3.24 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
66580
Drug name
Lutathera CA, Infusionslösung
Galenic form
LSPA
ATC Code
V10XX04
Authorization status
Z
Dispensation category
A
First authorization
25/06/2019
Authorization expiration date
31/12/9999
IT number
17.02.
Domain
Human medicine
Field of application
gastroenteropankreatische neuroendokrine Tumore (GEP‑NET)

Packaging details

Description (FR)
LUTATHERA CA sol perf 370 MBq/ml flac
Description (DE)
LUTATHERA CA Inf Lös 370 MBq/ml Durchstf
Market launch
25/06/2019
Narcotic (BTM)
No

Other packaging sizes